Salud financiera de hoja de balance de Thermo Fisher Scientific
Salud financiera controles de criterios 3/6
Thermo Fisher Scientific tiene un patrimonio de accionistas total de $45.6B y una deuda total de $35.6B, lo que sitúa su ratio deuda-patrimonio en 78%. Sus activos y pasivos totales son $97.1B y $51.5B respectivamente. El BAIT de Thermo Fisher Scientific es de $7.4B, por lo que su ratio de cobertura de intereses es de 17.4. Tiene efectivo e inversiones a corto plazo que ascienden a $7.3B.
Información clave
78.0%
Ratio deuda-patrimonio
US$35.61b
Deuda
| Ratio de cobertura de intereses | 17.4x |
| Efectivo | US$7.25b |
| Patrimonio | US$45.62b |
| Total pasivo | US$51.47b |
| Activos totales | US$97.10b |
Actualizaciones recientes sobre salud financiera
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Jun 07Recent updates
Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.
Dec 02Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07My Family Is Buying A Lot More Thermo Fisher Stock
Oct 31Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns
Aug 28Thermo Fisher: Cash Flow Returns On Investments Analysis
Aug 14Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 25Thermo Fisher Scientific: Continuing To Add To The Fortress
Jul 09Thermo Fisher: A Master Compounder In Healthcare
Jul 03These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Jun 07Buy Thermo Fisher, But With Caution
Jun 01Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($23.6B) de TMO superan a sus pasivos a corto plazo ($13.9B).
Pasivo a largo plazo: Los activos a corto plazo ($23.6B) de TMO no cubren sus pasivos a largo plazo ($37.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de TMO (62.2%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de TMO ha crecido de 65.9% a 78% en los últimos 5 años.
Cobertura de la deuda: La deuda de TMO está bien cubierta por el flujo de caja operativo (25.1%).
Cobertura de intereses: Los pagos de intereses de la deuda de TMO están bien cubiertos por el BAIT (17.4x cobertura).